Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-21-132480

Options or other derivatives

  • Director acquired 23,552 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nuechterlein Carole · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-10-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +23,552 $20.00 2031-10-28 23,552 23,522 D
Loading xslF345X03/tm2131250-12_4seq1.xml…